AbstractIn this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations
This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and D-chiro-...
Myo-inositol (MI) and D-chiro-inositol (DCI) are insulin second messengers, and MI is involved in fo...
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that develops in 10–15% of reproduct...
Polycystic ovary syndrome (PCOS) is one of the most common disorders among women of reproductive age...
The purpose of this study was to evaluate the effect of two doses of D-chiro-inositol (DCI) in combi...
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disease that involves menstrual dysf...
Introduction: This Experts' opinion provides an updated scientific support to gynecologists, obstetr...
Polycystic ovary syndrome (PCOS) is a symptom complex associated with increased amounts of circulati...
Polycystic ovary syndrome (PCOS) is a symptom complex associated with increased amounts of circulati...
The aim of this paper is to critically analyze the composition of many inositol-based products curre...
Introduction: This Experts’ opinion provides an updated scientific support to gynecologists, obstetr...
he aim of this paper is to critically analyze the composition of many inositol-based products curren...
The aim of this paper is to critically analyze the composition of many inositol-based products curre...
The present study aims to investigate the effects of the combined therapy myo-inositol (MI) plus d-c...
Polycystic ovarian syndrome (PCOS) involves dysfunction in the endocrinal, metabolic and reproductiv...
This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and D-chiro-...
Myo-inositol (MI) and D-chiro-inositol (DCI) are insulin second messengers, and MI is involved in fo...
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that develops in 10–15% of reproduct...
Polycystic ovary syndrome (PCOS) is one of the most common disorders among women of reproductive age...
The purpose of this study was to evaluate the effect of two doses of D-chiro-inositol (DCI) in combi...
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disease that involves menstrual dysf...
Introduction: This Experts' opinion provides an updated scientific support to gynecologists, obstetr...
Polycystic ovary syndrome (PCOS) is a symptom complex associated with increased amounts of circulati...
Polycystic ovary syndrome (PCOS) is a symptom complex associated with increased amounts of circulati...
The aim of this paper is to critically analyze the composition of many inositol-based products curre...
Introduction: This Experts’ opinion provides an updated scientific support to gynecologists, obstetr...
he aim of this paper is to critically analyze the composition of many inositol-based products curren...
The aim of this paper is to critically analyze the composition of many inositol-based products curre...
The present study aims to investigate the effects of the combined therapy myo-inositol (MI) plus d-c...
Polycystic ovarian syndrome (PCOS) involves dysfunction in the endocrinal, metabolic and reproductiv...
This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and D-chiro-...
Myo-inositol (MI) and D-chiro-inositol (DCI) are insulin second messengers, and MI is involved in fo...
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that develops in 10–15% of reproduct...